[A15-26] Insulin degludec (addendum to commission A15-10)
Last updated 20.08.2015
Project no.: A15-26
Commission: Commission awarded on 13.07.2015 by the Federal Joint Committee (G-BA).
Report type: Addendum
Status: Commission completed
Department/Division: Drug Assessment
Topic: Digestion, metabolism and hormones
Note:
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.